Mazzariello Gina's Form 4 filing
Amylyx Pharmaceuticals, Inc. (AMLX) · filed Aug 14, 2025
- Accession no.
- 0000950170-25-108912
- Filed
- Aug 14, 2025
- Trade date
- Aug 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $246.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazzariello GinaCIK 0001913765 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | SSaleDisposed | −15,000 | $8.07 | −$121,050 | 171,969 | Direct | |
| Aug 13, 2025 | Common Stock | SSaleDisposed | −15,000 | $8.34 | −$125,100 | 156,969 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.